Overview

Viraday Tablet is a fixed-dose combination of Tenofovir Disoproxil Fumarate (300 mg), Emtricitabine (200 mg), and Efavirenz (600 mg) manufactured by Cipla. It’s used once daily in HIV-1 antiretroviral therapy for viral suppression and immune recovery.

Mechanism of Action

Tenofovir (ntRTI) and Emtricitabine (NRTI) block reverse transcriptase, while Efavirenz (NNRTI) binds non-competitively to the enzyme, inhibiting HIV replication at multiple sites. ([turn0search14])

Usage & Administration

Take one tablet daily on an empty stomach at bedtime. Consistent daily intake is critical to prevent resistance. Avoid crushing or chewing. ([turn0search1], [turn0search3])

Common Side Effects

Possible adverse effects include nausea, dizziness, insomnia, headache, rash, depression, vivid dreams, and fatigue. Monitor psychiatric symptoms and advise caution. ([turn0search1])

Precautions & Warnings

Efavirenz is teratogenic—avoid in pregnancy. Monitor liver and renal function regularly. Do not consume alcohol; caution if underlying psychiatric or hepatic conditions. ([turn0search1], [turn0search2])

Disclaimer

This content is for product listing purposes only and does not replace professional medical advice. Use only under medical supervision.